论文部分内容阅读
Here,we employed structure-based ligand discovery techniques to explore the opportunity PPARγ ligands have been used as anti-diabetic drugs for more than ten years.It was originally thought that the therapeutic effect is due to its agonist activity in general transcription regulation of PPARγ.